Prior Auth Required

10314 - Cortes J, et al. Chronic myeloid leukaemia. The Lancet. 2021 Nov 20-26;398( ):1914-1926

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / ServiceCortes J, et al. Chronic myeloid leukaemia. The Lancet. 2021 Nov 20-26;398( ):1914-1926
Procedure / Service Description

chemotherapy in patients with intermediate-risk acute myeloid leukemia a randomized clinical trial. - controlled trials. Cancer. 2022 Jun;128(12)2288-2297. Cortelazzo S, et al. Mantle cell lymphoma. Crit Rev Oncol Hematol. 2012 Apr;82(1):78-101. Cortes J, et al. Chronic myeloid leukaemia. The Lancet. 2021 Nov 20-26;398(10314):1914-1926. Crocchiolo R, et al. Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non- Hodgkin’s lymphoma. Bone Marrow Transplant. 2013;48(2):249-52.

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.